- ¥7bn
- ¥4bn
- ¥1bn
- 42
- 35
- 13
- 15
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.33 | ||
| Price to Tang. Book | 2.33 | ||
| Price to Free Cashflow | 16.26 | ||
| Price to Sales | 7.23 | ||
| EV to EBITDA | 12.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.98% | ||
| Return on Equity | 11.72% | ||
| Operating Margin | 31.3% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | n/a | n/a | 1,000 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
K Pharma Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through a single segment of research, development, manufacture, and sale of pharmaceuticals, among others. The Company is engaged in induced pluripotent stem cell (iPS) drug discovery business. Neural progenitor cells, the cells that form the basis of nerves, are created from iPS cells, cryopreserved, and then 200000 cells are transplanted by injection into the site of a patient's spinal cord injury. The Company is also engaged in the research, development, manufacture and sale of regenerative medicine products.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 1st, 2016
- Public Since
- October 17th, 2023
- No. of Employees
- 15
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 11,604,600
- Address
- 8F, Tri-seven Roppongi, 7-7-7, Roppongi, MINATO-KU, 106-0032
- Web
- https://kpharma.co.jp/
- Phone
- +81 366293380
- Auditors
- KPMG AZSA LLC
Upcoming Events for 4896
Dividend For 4896.T - 0.0000 JPY
Similar to 4896
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the K Pharma share price?
As of Today at 19:13 UTC, shares in K Pharma are trading at ¥623. This share price information is delayed by 15 minutes.
How has the K Pharma share price performed this year?
Shares in K Pharma last closed at ¥623 and the price had moved by over the past 365 days. In terms of relative price strength the K Pharma share price has matched the Nikkei 225 Index by over the past year.
What are the analyst and broker recommendations for K Pharma?
There is no consensus recommendation for this security.
What is the K Pharma dividend yield?
K Pharma does not currently pay a dividend.
Does K Pharma pay a dividend?
K Pharma does not currently pay a dividend.
When does K Pharma next pay dividends?
K Pharma does not currently pay a dividend.
How do I buy K Pharma shares?
To buy shares in K Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of K Pharma?
As of the previous close price of ¥623, shares in K Pharma had a market capitalisation of ¥7bn.
Where are K Pharma shares listed?
Here are the trading details for K Pharma:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4896
What kind of share is K Pharma?
Based on an overall assessment of its quality, value and momentum K Pharma is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a K Pharma share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the K Pharma share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like K Pharma. Over the past six months, its share price has underperformed the Nikkei 225 Index by -32.05%.
As of the last closing price of ¥623, shares in K Pharma were trading -2.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the K Pharma PE Ratio?
The K Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥623.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of K Pharma?
We do not have data on K Pharma's directors